You seem to be intentionally disingenuous given the whole design and purpose of the 002 adaptive study was to first to identify the min most effective dose (in Stage 1) and then have the FDA agree to our recommended dosage for Stage 2 (based on the interim read out of Stage 1 dosings plus additional supportive studies on 2mg/kg x2).
We have to wait for the FDA teams to review our revised IND submission and then respond before we can restart and NOT beforehand. IMO there very strong basis for them to allow our preferred dosage for Stage 2. In other words almost a certainty once they review the safety profile.
- Forums
- ASX - By Stock
- PAR
- Where we at?
Where we at?, page-278
-
- There are more pages in this discussion • 429 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.8¢ |
Change
0.008(3.41%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
22.5¢ | 23.5¢ | 22.5¢ | $15.95K | 69.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 151036 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 132937 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 151795 | 0.225 |
11 | 89940 | 0.220 |
7 | 98958 | 0.215 |
5 | 131050 | 0.210 |
4 | 104982 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 132937 | 2 |
0.235 | 139523 | 8 |
0.240 | 22000 | 1 |
0.250 | 55833 | 2 |
0.255 | 9785 | 1 |
Last trade - 12.56pm 15/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online